| Company | Designation | Period |
|---|---|---|
| Genotypic Technology | Deputy General Manager, India Business Unit | Sep 2011 – Oct 2013 |
| Genotypic Technology | General Manager | Oct 2013 – Mar 2015 |
| Invitrogen | Team Lead, Epigenetics and Gene Expression Profiling | Jun 2005 – Jan 2009 |
| Yale University | Post Doctoral fellow | Jun 2002 – May 2005 |
| Thermo Fisher Scientific | Technical Manager, BID | Jul 2010 – Sep 2011 |
| University of Connecticut Health Center | Post Doc Fellow | Jul 2001 – Jun 2002 |
| Life Technologies | Technical Sales Specialist, Bioinformatics | Jan 2010 – Jun 2010 |
| Invitrogen, Part of Life Technologies | Application Scientist | Jan 2009 – Dec 2009 |
| NCBS | Ph.D. Student | Jan 1998 – Jan 2001 |
| Yet to be named | Entrepreneur | Aug 2016 – Oct 2016 |
| Genotypic Technology | Vice President | Apr 2015 – Jul 2016 |
| theraCUES | Founder and CEO | Oct 2016 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Theracues corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Gopalakrishna Ramaswamy's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Theracues's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)